JL18008 not checked
Jecho Biopharmaceuticals Co., Ltd.
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Participants receive JL18008 20 μg/kg by intramuscular injection once weekly for 4 weeks, in addition to their stable combination antiretroviral therapy (cART).”In the company’s words, NCT07579741 on ClinicalTrials.gov
- Tested for
- HIV Infections, HIV
- Main trialPhase 1/2
- “The Phase Ib clinical trial is an add-on study based on combination antiretroviral therapy (cART). It adopts a multicenter, randomized, double-blind, placebo-controlled, multiple-dose design to evaluate the safety and efficacy of multiple intramuscular injections of JL18008 added to cART in HIV immunological non-responders (INRs). Based on the Phase Ia clinical data, three dose groups are planned for the Phase Ib trial: 20, 40, and 70 μg/kg of JL18008. Each group is planned to enroll 10 subjects (8 receiving active drug and 2 receiving placebo). All subjects must maintain their original cART…”In the company’s words, NCT07579741 on ClinicalTrials.gov
Other drugs for HIV Infections
- ACC017Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Phase 3
- AlimatravirMerck & Co. · Phase 3
- IslatravirMerck & Co. · Phase 2/3
- UlonivirineMerck & Co. · Phase 2/3
- DOVATOViiV Healthcare · Phase 3
- ISL/ULOMerck & Co. · Phase 2/3
Coming up2
- 12 Feb 2027Phase 1/2 trial completes · ClinicalTrials.gov
- 20 Dec 2029Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Recruiting | 12 Feb 2027 | A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders | |
| Phase 1Not yet recruiting | 20 Dec 2029 | Recombinant Human Interleukin-7 (JL18008) for the Treatment of HIV-Infected Immunological Non-Responders | |
| Phase 1Completed | 5 Aug 2025 | To Evaluate the Safety of JL18008 |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026